INO-5401
842686, UPCC 06019
Phase 1 small_molecule active
Quick answer
INO-5401 for BRCA1/2 Mutation is a Phase 1 program (small_molecule) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- BRCA1/2 Mutation
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active